Who can take part?
Patients with advanced solid tumour and standard therapy has either been exhausted or is not available.
What is involved for you?
You will receive the study drug once every 3 weeks through intravenous (IV) infusion, which will take approximately one hour. You will be required to attend the clinic at least every week during treatment for a physical assessment, blood tests, ECGs and ongoing assessments. You will also receive ongoing tumour assessments via scans.